Acquired Company

Relief Therapeutics completed a business combination with NeuroX Group SA to form MindMaze Therapeutics Holding SA, and the combined company began trading on SIX Swiss Exchange as MindMaze Therapeutics under ticker MMTX starting December 15, 2025.

MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland. Show more

Location: Chemin de Roseneck 5, Lausanne, 1006, Switzerland | Website: https://mindmazetherapeutics.com | Industry: | Sector:

Market Cap

16.3M

52 Wk Range

$1.29 - $4.88

Previous Close

$1.46

Open

$1.46

Volume

804

Day Range

$1.46 - $1.60

Enterprise Value

34.19M

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

34.53%

Institutional Own.

13.58%

Qtr Updated

06/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RLF-TD011 (APR-TD011) Details Epidermolysis bullosa	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.